Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
In a decision that, in retrospect, is not surprising (in view of the haste with which the Court took up the case after granting certiorari; see “Solicitor General Proves Persuasive; Supreme Court Grants Hikma’s Certiorari Petition“), the Supreme Court in …